Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we inform that the Board of Directors at its meeting held on 31st August, 2026 approved the following:1. Alteration of the Main Objects Clause III(A) of the Memorandum of Association by inserting a new Main Object No. 4 relating to nutraceuticals, natural extracts and food ingredients, subject to approval of Members by Special Resolution at the ensuing 38th Annual General Meeting.2. Revised Notice of the 38th Annual General Meeting to be held on 25th September, 2026.
Godavari Drugs Limited Press Release Aug 31 2026
Filed with BSE · · 2 pages · English
Release
Earlier from Godavari Drugs
- Godavari Drugs Limited Press Release Aug 17 2026
- Godavari Drugs Limited Press Release Aug 14 2026
- Godavari Drugs Limited Press Release Jul 11 2026
- Godavari Drugs Limited Press Release Jun 23 2026
- Godavari Drugs Limited Press Release May 27 2026
Later from Godavari Drugs
- Godavari Drugs Limited Press Release Sep 01 2026
- Godavari Drugs Limited Press Release Sep 03 2026
- Godavari Drugs Limited Press Release Sep 21 2026
- Godavari Drugs Limited Press Release Sep 25 2026
- Godavari Drugs Limited Press Release Sep 26 2026
Follow Godavari Drugs into a list and get an email when it puts out news.
Follow Godavari Drugs